moatshark My

All holdings

IQVIA Holdings

IQV

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$2.4bn
Combined value at quarter end
Last quarter
2 bought
1 sold or trimmed
Fund portfolios
3
Funds holding it
See which
Price at Q2 ’26 end
$193.22
+13.3% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+12.1%Q3 ’24
-17.1%Q4 ’24
-10.3%Q1 ’25
-10.6%Q2 ’25
+20.5%Q3 ’25
+18.7%Q4 ’25
-24.3%Q1 ’26
+13.3%Q2 ’26
Q3 ’24: +12.1%; Q4 ’24: -17.1%; Q1 ’25: -10.3%; Q2 ’25: -10.6%; Q3 ’25: +20.5%; Q4 ’25: +18.7%; Q1 ’26: -24.3%; Q2 ’26: +13.3%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

3Q4 ’23
3Q1 ’24
3Q2 ’24
3Q3 ’24
3Q4 ’24
3Q1 ’25
5Q2 ’25
5Q3 ’25
5Q4 ’25
4Q1 ’26
3Q2 ’26
0Q3 ’26
Q4 ’23: 3; Q1 ’24: 3; Q2 ’24: 3; Q3 ’24: 3; Q4 ’24: 3; Q1 ’25: 3; Q2 ’25: 5; Q3 ’25: 5; Q4 ’25: 5; Q1 ’26: 4; Q2 ’26: 3; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes IQVIA Holdings.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding IQVIA Holdings
Harris Associates (Oakmark)3.1%$2.4bn$2.4bnAdded 0.0%13 qtrs
Vulcan Value Partners1.5%$50.2m$50.2mAdded +4.7%5 qtrs
Markel Group0.1%$9.1m$9.1mUnchanged14 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of IQVIA Holdings
Bought or soldFiling
2 Sep 2026Berkshire James G.See Remarks▼ Sold2,668$261.33$697kForm 4
3 Aug 2026Staub W RichardSee Remarks▼ Sold5,500$232.68$1.3mForm 4
31 Jul 2026Patel BhavikSee Remarks▼ Sold1,855$235.27$436kForm 4
29 Jul 2026Bousbib AriSee Remarks▼ Sold53,191$244.78$13.0mForm 4
29 Jul 2026Bousbib AriSee Remarks▼ Sold44,039$246.08$10.8mForm 4
29 Jul 2026Sherbet EricSee Remarks▼ Sold5,000$249.16$1.2mForm 4
29 Jul 2026Bousbib AriSee Remarks▼ Sold4,584$246.85$1.1mForm 4
29 Jul 2026Bousbib AriSee Remarks▼ Sold4,465$247.10$1.1mForm 4
29 Jul 2026Cherofsky KeriannSee Remarks▼ Sold558$245.21$137kForm 4

About the company

Sector
Health care · Services-Commercial Physical & Biological Research
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
165m at 21 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$5.1bn2013
$5.7bn2015
$9.7bn2017
$11bn2019
$14bn2021
$15bn2023
$16bn2025
2013: $5.1bn; 2014: $5.5bn; 2015: $5.7bn; 2016: $6.9bn; 2017: $9.7bn; 2018: $10bn; 2019: $11bn; 2020: $11bn; 2021: $14bn; 2022: $14bn; 2023: $15bn; 2024: $15bn; 2025: $16bn
IQVIA Holdings revenue and net income by year
YearRevenueNet income
2025$16bn$1.4bn
2024$15bn$1.4bn
2023$15bn$1.4bn
2022$14bn$1.1bn
2021$14bn$966m
2020$11bn$279m
2019$11bn$191m
2018$10bn$259m
2017$9.7bn$1.3bn
2016$6.9bn$72.0m
2015$5.7bn$387m
2014$5.5bn$357m
2013$5.1bn$227m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

Sold out last quarter

In fund portfolios

US-registered funds run by these managers that hold IQVIA Holdings, from their latest N-PORT filings.

Funds holding IQVIA Holdings
Oakmark Global Select FundHarris Associates (Oakmark)6.5%$53.9m30 Jun 2026
Vulcan Value Partners FundVulcan Value Partners3.5%$8.0m31 Jul 2026
Oakmark Global FundHarris Associates (Oakmark)3.3%$35.3m30 Jun 2026